Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Dongyang Liu, PhD (he/him/his)

Deputy Director
Drug Clinical Trial Center, Peking University Third Hospital
Beijing, Beijing, China (People's Republic)

Dr. Dongyang Liu is a professor & director of Clinical Pharmacology and Pharmacometrics Office (CPPO), and deputy director of Drug Clinical Trial Center of Peking University Third Hospital (PUTH). Up to now, he was responsible for clinical trials or model informed drug development studies of more than 50 novel drugs as PI and published more than 60 international peered articles, such as Acta pharmaceutica Sinica B, EClinicalMedicine, Clin Pharmacokinet, Clin Infect Dis, as the first or corresponding author. He was invited to be the vice chairman of committeeman of Professional Committee of Pharmacometrics, and committeeman of Professional Clinical Pharmacology in Chinese Pharmacological Society as well as Associate Editor of BDD and Editor of JPKPD journal. He earned National Innovation Competition Award (Rank Six). Currently, he is majorly interested in 1) early phase clinical development for new drugs, 2) PBPK-PD-Disease model research for New drug development and precision dosing.

Disclosure(s): No financial relationships to disclose

Presentation(s):